1. Anlotinib Versus Sunitinib as First‐Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial. (22nd March 2019) Authors: Zhou, Ai‐Ping; Bai, Yuxian; Song, Yan; Luo, Hong; Ren, Xiu‐Bao; Wang, Xiuwen; Shi, Benkang; Fu, Cheng; Cheng, Ying; Liu, Jiyan; Qin, Shukui; Li, Jun; Li, Hanzhong; Bai, Xianzhong; Ye, Dingwei; Wang, Jinwan; Ma, Jianhui Journal: Oncologist Issue: Volume 24:Number 8(2019) Page Start: e702 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The enhanced expression of estrogen‐related receptor α in human bladder cancer tissues and the effects of estrogen‐related receptor α knockdown on bladder cancer cells. Issue 8 (11th April 2019) Authors: Ye, Xinqing; Guo, Jinan; Zhang, Hongxiang; Meng, Qinggui; Ma, Yun; Lin, Rui; Yi, Xianlin; Lu, Haoyuan; Bai, Xianzhong; Cheng, Jiwen Journal: Journal of cellular biochemistry Issue: Volume 120:Issue 8(2019) Page Start: 13841 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗